Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aquinox Pharmaceuticals Inc (NASDAQ:AQXP)

16.16
Delayed Data
As of Sep 03
 -0.79 / -4.66%
Today’s Change
1.38
Today|||52-Week Range
55.75
+115.47%
Year-to-Date

Today’s Trading

Previous close16.95
Today’s open16.78
Day’s range16.15 - 17.10
Volume120,488
Average volume (3 months)1,914,657
Market cap$181.8M
Dividend yield--
Data as of 3:59pm ET, 09/03/2015

Growth & Valuation

Earnings growth (last year)-216.09%
Earnings growth (this year)+22.18%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.02

Competitors

 Today’s
change
Today’s
% change
CATBCatabasis Pharmaceut...-0.48-4.01%
RPRXRepros Therapeutics ...-0.04-0.54%
AGRXAgile Therapeutics I...-0.23-2.74%
MSLIMerus Labs Internati...-0.04-2.33%
Data as of 3:59pm ET, 09/03/2015

Financials

Next reporting dateNovember 3, 2015
EPS forecast (this quarter)-$0.49
Annual revenue (last year)$0.00
Annual profit (last year)-$23.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
David J. Main
Chief Financial Officer &
Vice President
Kamran Alam
Corporate headquarters
Vancouver, British Columbia

Forecasts

Partner Offers